Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director | July 01, 2026 | July 02, 2026 |
| Credo Technology Group Holding LtdCRDO · Entity 3082 | Director | October 13, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,801 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 1,658 · Balance 14,801 F1: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates.
F2: The amount reported includes shares subject to unvested restricted stock units.
Credo Technology Group Holding Ltd
Report date October 13, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 8,239 |
Reported balance
After 2026-10-13 transaction · row 1
1 source rowRow 1 · 2026-10-13 · Grant · Acquired 1,222 · Balance 8,239 F1: Represents restricted stock units that will fully vest upon the earlier of (a) the one year anniversary of the vesting commencement date (the day following the Issuer's 2026 Annual General Meeting), or (b) the date of the Issuer's 2027 Annual General Meeting, in each case subject to continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will fully vest upon the earlier of (a) the one year anniversary of the vesting commencement date (the day following the Issuer's 2026 Annual General Meeting), or (b) the date of the Issuer's 2027 Annual General Meeting, in each case subject to continued service through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2026 Filed Oct 14, 2026 20:29 UTC | Credo Technology Group Holding Ltd CRDO · Entity 3082 | GrantOrdinary Shares | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-065885 · wk-form4_1792009742.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,239 F1 · shares: Represents restricted stock units that will fully vest upon the earlier of (a) the one year anniversary of the vesting commencement date (the day following the Issuer's 2026 Annual General Meeting), or (b) the date of the Issuer's 2027 Annual General Meeting, in each case subject to continued service through the vesting date. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000181 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,801 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 21:45 UTC | Credo Technology Group Holding Ltd CRDO · Entity 3082 | SaleOrdinary Shares | 1,100 | $236.35 | $259,979.50 |
DisclosureSEC source: 0001628280-26-042590 · wk-form4_1781214343.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,017 Read SEC document |
| May 23, 2026 Filed May 26, 2026 22:38 UTC | Credo Technology Group Holding Ltd CRDO · Entity 3082 | GrantOrdinary Shares | 890 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-038274 · wk-form4_1779835082.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,117 F1 · shares: Represents restricted stock units that will fully vest upon the earlier of (a) the one year anniversary of the vesting commencement date (the day following the Issuer's 2025 Annual General Meeting), or (b) the date of the Issuer's 2026 Annual General Meeting, in each case subject to continued service through the vesting date. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:40 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001040470-26-000126 · primary_01.xml · derivative · entry 3 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2028-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:40 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 8,000 | $82.63 | $661,040.00 |
DisclosureSEC source: 0001040470-26-000126 · primary_01.xml · nonDerivative · entry 2 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,143 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:40 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 8,000 | $2.25 | $18,000.00 |
DisclosureSEC source: 0001040470-26-000126 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001040470-26-000092 · primary_01.xml · derivative · entry 4 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 7,000 shares Expires 2028-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,000 | $71.49 | $500,430.70 |
DisclosureSEC source: 0001040470-26-000092 · primary_01.xml · nonDerivative · entry 3 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,143 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 7,000 | $2.25 | $15,750.00 |
DisclosureSEC source: 0001040470-26-000092 · primary_01.xml · nonDerivative · entry 2 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 01:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,500 | $70.05 | $245,157.50 |
DisclosureSEC source: 0001040470-26-000092 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,143 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:49 UTC | Credo Technology Group Holding Ltd CRDO · Entity 3082 | GrantOrdinary Shares | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045376 · wk-form4_1760734150.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,227 F1 · shares: Represents restricted stock units that will fully vest upon the earlier of (a) the one year anniversary of the vesting commencement date (the day following the Issuer's 2025 Annual General Meeting), or (b) the date of the Issuer's 2026 Annual General Meeting, in each case subject to continued service through the vesting date. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 20:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,335 | $24.76 | $156,822.93 |
DisclosureSEC source: 0001040470-25-000050 · primary_01.xml · nonDerivative · entry 2 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,643 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 09, 2025 Filed Oct 10, 2025 20:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,665 | $24.87 | $66,278.55 |
DisclosureSEC source: 0001040470-25-000050 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,978 Read SEC document |
| July 02, 2025 Filed Jul 9, 2025 18:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000850 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,643 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 19, 2025 Filed Jul 9, 2025 17:50 UTC | Credo Technology Group Holding Ltd CRDO · Entity 3082 | GrantOrdinary Shares | 6,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-034632 · wk-form4_1752083399.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,577 F1 · shares: Represents restricted stock units that will vest in substantially equal one third installments on each of March 20, 2026, March 20, 2027 and March 20, 2028, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| July 30, 2024 Filed Jul 30, 2024 20:41 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $18.59 | $185,900.00 |
DisclosureSEC source: 0001593968-24-001031 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,390 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 20:49 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000972 · primary_01.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,390 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 27, 2023 Filed Oct 28, 2023 01:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 4,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-013499 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,125 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009085 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,665 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,330 | $30.00 | $69,900.00 |
DisclosureSEC source: 0001654954-23-000554 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,665 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,325 | $20.00 | $46,500.00 |
DisclosureSEC source: 0001654954-22-014021 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,995 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013927 · section16.xml · nonDerivative · entry 2 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,320 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:20 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013927 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,320 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,550 | $16.12 | $24,986.00 |
DisclosureSEC source: 0001654954-22-013585 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,158 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.31 to $17.39, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 00:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 2,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-011241 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 6,708 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 4,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007947 · section16.xml · nonDerivative · entry 1 DANESH FARIBA · CIK 0001228855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,693 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.